Global X Japan Co. Ltd. Raises Holdings in Intuitive Surgical, Inc. $ISRG

Global X Japan Co. Ltd. increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.4% in the 4th quarter, HoldingsChannel reports. The firm owned 51,005 shares of the medical equipment provider’s stock after buying an additional 10,980 shares during the quarter. Intuitive Surgical makes up 2.2% of Global X Japan Co. Ltd.’s portfolio, making the stock its 13th largest position. Global X Japan Co. Ltd.’s holdings in Intuitive Surgical were worth $28,887,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Intuitive Surgical by 0.8% during the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after buying an additional 263,828 shares in the last quarter. State Street Corp lifted its position in shares of Intuitive Surgical by 1.2% in the second quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after acquiring an additional 182,871 shares in the last quarter. Capital World Investors boosted its stake in shares of Intuitive Surgical by 1.5% during the third quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock valued at $3,456,223,000 after acquiring an additional 116,034 shares during the last quarter. Norges Bank acquired a new stake in shares of Intuitive Surgical during the second quarter valued at $2,569,260,000. Finally, Invesco Ltd. increased its position in Intuitive Surgical by 4.8% during the 2nd quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock worth $2,402,488,000 after purchasing an additional 201,159 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of Intuitive Surgical stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Myriam Curet sold 105 shares of the business’s stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total transaction of $51,864.75. The SEC filing for this sale provides additional information. Insiders have sold a total of 32,943 shares of company stock valued at $17,279,568 in the last ninety days. 0.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on ISRG shares. Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price for the company in a research note on Wednesday, March 11th. Raymond James Financial raised their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Truist Financial lifted their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Evercore reduced their price objective on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a research note on Friday, January 23rd. Finally, Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $614.95.

Intuitive Surgical Trading Down 0.3%

Shares of NASDAQ:ISRG opened at $468.55 on Friday. The stock’s 50-day moving average price is $496.15 and its two-hundred day moving average price is $513.04. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The firm has a market cap of $166.40 billion, a price-to-earnings ratio of 59.39, a PEG ratio of 3.63 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.21 EPS. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive is taking direct control of da Vinci and Ion distribution in Southern Europe to improve sales, service and system availability — a move that should support long‑term revenue and customer uptime in a strategic region. Intuitive Surgical Extends Southern Europe Reach As Stock Trades Below Targets
• Positive Sentiment: Wall Street and retail commentary remain constructive: several recent pieces label ISRG a top pure‑play robotics buy and say analyst recommendations are generally favorable, supporting investor conviction around market leadership and long runway. Is Intuitive Surgical Inc. (ISRG) the best pure-play robotics stock to buy now?
• Positive Sentiment: Former management highlights Intuitive’s competitive moat in clinician training and ecosystem lock‑in — an important qualitative advantage that supports recurring procedure volume and replacement/system upgrade demand. Intuitive Surgical stock moat lies in training, former exec says
• Neutral Sentiment: Underlying fundamentals remain solid: the company posted a revenue and EPS beat in the most recent quarter (strong procedure growth and high margins), but those results are already priced into a premium multiple, so impact on near‑term price is mixed.
• Negative Sentiment: Shares have been under pressure — trading below some analyst targets and showing YTD weakness — which can amplify downside on headline volatility or broader market risk‑off days. Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights
• Negative Sentiment: High valuation (elevated P/E) means the stock is sensitive to execution misses, slower procedure adoption or tougher macro conditions — risks investors are currently re‑pricing into the stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.